Suchergebnisse - "Kuhn, Michael"

PubPharm (11)

1

Terlipressin therapy is associated with increased risk of colonisation with multidrug-resistant bacteria in patients with decompensated cirrhosis

enthalten in: Alimentary pharmacology & therapeutics | 2024

von Mücke, M. | Hernández-Tejero, M. | Gu, W. | +30

2

Antibacterial activity of novel bacterial topoisomerase inhibitors against key veterinary pathogens

enthalten in: Veterinary microbiology | 2023

von Phelps, H. | Kuhn, M. | Lu, Y. | +3

3

Unravelling the collateral damage of antibiotics on gut bacteria

enthalten in: Nature | 2021

von Maier, L. | Goemans, C. | Wirbel, J. | +19

4

Dispersal strategies shape persistence and evolution of human gut bacteria

enthalten in: Cell host & microbe | 2021

von Hildebrand, F. | Gossmann, T. | Frioux, C. | +7

CommentIn: Cell Host Microbe. 2021 Jul 14;29(7):1163-1164. - PMID 34265247

5

Significant interaction between high-dose methotrexate and high-dose piperacillin-tazobactam causing reversible neurotoxicity and renal failure in an osteosarcoma patient

enthalten in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners | 2021

von Krämer, I. | Rosentreter, J. | Fried, M. | +1

6

Extensive impact of non-antibiotic drugs on human gut bacteria

enthalten in: Nature | 2018

von Maier, L. | Pruteanu, M. | Kuhn, M. | +10

CommentIn: Nat Rev Microbiol. 2018 Jun;16(6):329. - PMID 29599456

7

Marsupial and monotreme cathelicidins display antimicrobial activity, including against methicillin-resistant Staphylococcus aureus

enthalten in: Microbiology (Reading, England) | 2017

von Peel, E. | Cheng, Y. | Djordjevic, J. | +3

8

LpxC inhibitors as new antibacterial agents and tools for studying regulation of lipid A biosynthesis in Gram-negative pathogens

enthalten in: mBio | 2014

von Tomaras, A. | McPherson, C. | Kuhn, M. | +10

9

Discovery of Dap-3 polymyxin analogues for the treatment of multidrug-resistant Gram-negative nosocomial infections

enthalten in: Journal of medicinal chemistry | 2013

von Magee, T. | Brown, M. | Starr, J. | +32

10

Evaluation of pharmacokinetic/pharmacodynamic relationships of PD-0162819, a biotin carboxylase inhibitor representing a new class of antibacterial compounds, using in vitro infection models

enthalten in: Antimicrobial agents and chemotherapy | 2012

von Ogden, A. | Kuhn, M. | Dority, M. | +6